Tjalling Erkelens

Chairman of the Board, Bedrocan International (Netherlands).

Bedrocan International, whose subsidiary Bedrocan Nederland is the only company licensed by the Dutch Ministry of Health to produce pharmaceutical-grade cannabis for patients and research.

For many years, ‘Bedrocan’ represents the development of unique methods of producing cannabis to pharmaceutical standards at a level achieved by no other company in the world. Bedrocan International has formed numerous partnerships with governments, universities, research organisations and private companies in order to discover how herbal cannabis can meet the strict regulatory demands of modern medicine while maintaining the integrity of the plant. The results are reflected in the company’s significant contributions to social, chemical and clinical research on cannabis over the past decades. No other private company in the world has made such contributions to the use of cannabis as medicine.